Zevra Therapeutics, Inc. (ZVRA)
NASDAQ · Healthcare
Zevra Therapeutics, Inc. Cash on Hand 2013–2025
Zevra Therapeutics, Inc. annual cash on hand history from 2014 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Zevra Therapeutics, Inc. cash on hand as of December 31, 2025: 62.4M, a 84.72% increase year-over-year.
- Zevra Therapeutics, Inc. cash on hand for 2025 were 62.4M, a 84.72% increase from 2024.
- Zevra Therapeutics, Inc. cash on hand for 2024 were 33.8M, a 21.52% decrease from 2023.
- Zevra Therapeutics, Inc. cash on hand for 2023 were 43.0M, a 34.24% decrease from 2022.
- Zevra Therapeutics, Inc. cash on hand for 2022 were 65.5M.
Cash on Hand
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Zevra Therapeutics, Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $62 |
| 2024 | $34 |
| 2023 | $43 |
| 2022 | $65 |
| 2021 | $112 |
| 2020 | $4 |
| 2019 | $3 |
| 2018 | $18 |
| 2015 | $32 |
| 2014 | $10 |
Zevra Therapeutics, Inc. Cash on Hand — FAQ
Zevra Therapeutics, Inc. (ZVRA) cash on hand over the last 11 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ZVRA's cash on hand history?
The chart and table above show Zevra Therapeutics, Inc.'s cash on hand by year and by quarter, including the growth rate.